In breast cancer, studies have revealed that SPOP targets substrates such as c-Myc, steroid receptor coactivator 3 (SRC-3) and progesterone receptor (PR), thus functioning as a tumor suppressor [25,36,37]. This evidence concerns the gene NCOA3 and breast cancer.